Andrea Gmür

ORCID: 0000-0002-0139-5732
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Radiomics and Machine Learning in Medical Imaging
  • Gastric Cancer Management and Outcomes
  • Cancer Genomics and Diagnostics
  • Endometriosis Research and Treatment
  • Colorectal Cancer Screening and Detection
  • Ovarian function and disorders
  • Assisted Reproductive Technology and Twin Pregnancy
  • Liver Disease Diagnosis and Treatment
  • Reproductive Biology and Fertility
  • Genetic factors in colorectal cancer
  • Cervical Cancer and HPV Research
  • Uterine Myomas and Treatments

University Hospital of Bern
2018-2024

University of Bern
2018-2024

Klinik für Frauenheilkunde
2024

ObjectiveThe prognostic significance of positive peritoneal cytology in endometrial cancer has long been debated. In 2009, the Fédération Internationale de Gynécologie et d'Obstétrique (FIGO) removed as a staging criterion from system. However, there is still evidence that may decrease survival among patients with cancer. The aim this study was to determine different molecular subgroups.MethodsThis included who underwent primary surgical treatment between 2004 and 2015 at Bern University...

10.1016/j.ygyno.2024.01.006 article EN cc-by Gynecologic Oncology 2024-01-23

Lymphovascular space invasion (LVSI) is a known prognostic factor for oncological outcome in endometrial cancer patients. However, little about the value of LVSI among different molecular subgroups. The aim this study was to determine dependence from signature.This included patients who underwent primary surgical treatment between February 2004 and 2016 at Karolinska University Hospital, Sweden Bern Switzerland (KImBer cohort). All cases had complete analysis performed on tumor according WHO...

10.1136/ijgc-2023-004606 article EN cc-by-nc International Journal of Gynecological Cancer 2023-09-04

Abstract Background and aim The Eastern Cooperative Oncology Group Performance Status (ECOG PS) is a strong predictor of survival for patients with hepatocellular carcinoma (HCC), used liver function tumour burden in the Barcelona Clinic Liver Cancer (BCLC) staging system. This work assesses whether health‐related quality life (HRQL), measured by Functional Assessment Therapy‐Hepatobiliary (FACT‐Hep) questionnaire, discriminates HCC terms adds prognostic information to ECOG PS. Methods A...

10.1111/liv.13711 article EN Liver International 2018-02-01

Lynch syndrome is an inherited tumor caused by a pathogenic germline variant in DNA mismatch repair genes. As the leading cause of hereditary endometrial cancer, international guidelines recommend universal screening women with cancer. However, testing for not yet well established clinical practice. The aim this study was to evaluate adherence our algorithm. A retrospective, single-center cohort conducted all cancer patients undergoing surgical treatment at Bern University Hospital,...

10.3390/cancers16030671 article EN Cancers 2024-02-04

The aim of this study was to examine the role pre-sacral sentinel lymph nodes (SLNs) in patients with uterine cancer. This retrospective cohort includes endometrial or cervical cancer who underwent minimally invasive indocyanine green SLN mapping at Bern University Hospital from December 2012 2022. A complete ultra-staging SLNs performed all cases. total 616 were included study. mean age 61.6 years (standard deviation ± 13.8) and body mass index 28.2 kg/m2 7.3). Endometrial present 466...

10.1016/j.ijgc.2024.100032 article EN International Journal of Gynecological Cancer 2024-12-31

Zusammenfassung: Zwillingsschwangerschaften mit kompletter Blasenmole und Koexistenz eines augenscheinlich gesunden Feten sind einer geschätzten Prävalenz von 1:22000 -1:100000 sehr selten. Die Fortführung der Schwangerschaft birgt ein hohes Risiko für geburtshilfliche Komplikationen (Blutung, Präeklampsie, Frühgeburtlichkeit, Abort/ intrauteriner Fruchttod, Hyperthyreoidismus) Lebendgeburtenrate nur 43% bzw. einem neonatalen Überleben an Tag 8 36%. Unabhängig vom Gestationsalter Beendigung...

10.1055/s-0044-1790871 article DE Geburtshilfe und Frauenheilkunde 2024-10-01
Coming Soon ...